Atlas Trials

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19

Clinical trial NCT04530396 · UNKNOWN

Trial details

NCT number
NCT04530396
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19 Prevention
Start date
2020-09-07
Primary completion
2021-05-01
Enrollment
33758

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.